Maureen C. Ryan

3.7k citations

35 papers · 3.1k indexed · 1 hit paper · h-index 19

Impact in

Immunology and Allergy top 0.2%
- Cell Adhesion Molecules Research
Cell Biology top 1%
- Cellular Mechanics and Interactions
- Skin and Cellular Biology Research

Papers in

Immunology and Allergy 15
- Cell Adhesion Molecules Research 15
Hematology 7
- Multiple Myeloma Research and Treatments 7
- Acute Myeloid Leukemia Research 3

Co-authors: William G. Carter Linda J. Sandell Susana G. Gil Yuko Miyashita Keesook Lee Leia M. Smith Richard Tizard Donald R. VanDevanter
Journals: Cancer Research (8 papers)Blood (8 papers)Molecular Cancer Therapeutics (2 papers)British Journal of Cancer (2 papers)Journal of Investigative Dermatology (2 papers)
Partner nations: United States South Korea Germany

In The Last Decade

Maureen C. Ryan

35 papers receiving 3.0k citations

Hit Papers

align trajectories log scale

Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes 1991 · 688 citations

Peers

Countries citing papers authored by Maureen C. Ryan

Since Specialization

Citations

This map shows the geographic impact of Maureen C. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen C. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen C. Ryan more than expected).

Fields of papers citing papers by Maureen C. Ryan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen C. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen C. Ryan. The network helps show where Maureen C. Ryan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Maureen C. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maureen C. Ryan Line = papers co-authored together Maureen C. Ryan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SGN-B6A: A New Vedotin Antibody–Drug Conjugate Directed to Integrin Beta-6 for Multiple Carcinoma Indications Molecular Cancer Therapeutics ·Robert P. Lyon, Mechthild Jonas, Christopher Frantz, Esther S. Trueblood, Roma Yumul, Lori Westendorf, W. H. Hammond, Jackie L. Stilwell, M. N. Rozenvasser, A. Ermisch, Vineet Kumar, Gabriela I. Patilea‐Vrana, Kerry Klussman, Maureen C. Ryan	2023	12
2	SGN-CD30C, an Investigational CD30-Directed Camptothecin Antibody-Drug Conjugate (ADC), Shows Strong Anti Tumor Activity and Superior Tolerability in Preclinical Studies Blood ·Maureen C. Ryan, A Capelli, John Lee, Ryan A. Heiser, 忠幸林, Carmen Cecilia Torres Burgos, Shcherbak Em, Jessica K. Simmons, Melissa Conerly, Peter D. Senter, Scott C. Jeffrey	2020	3
3	A coiled-coil masking domain for selective activation of therapeutic antibodies Nature Biotechnology ·朱英军, Xinqun Zhang, Roma Yumul, Weiping Zeng, Ivan J. Stone, 刘晓越, Marinov Peter, Julia H. Cochran, Jessica K. Simmons, Maureen C. Ryan, Robert P. Lyon, Peter D. Senter, Matthew R. Levengood	2019	64
4	Denintuzumab Mafodotin Stimulates Immune Responses and Synergizes with CD20 Antibodies to Heighten Anti-Tumor Activity in Preclinical Models of Non-Hodgkin Lymphoma Blood ·Heather A. Van Epps, Ryan A. Heiser, Anthony Cao, Kerry Klussman, Changpu Yu, Ivan J. Stone, Jason Neale, Shyra J. Gardai, Che‐Leung Law, Maureen C. Ryan	2016	2
5	SGN-CD19B, a Pyrrolobenzodiazepine (PBD)-Based Anti-CD19 Drug Conjugate, Demonstrates Potent Preclinical Activity Against B-Cell Malignancies Blood ·Maureen C. Ryan, Brian Schimpf, Martha E. Anderson, Weiping Zeng, Kim K. Emmerton, Jamie B. Miyamoto, Heather Kostner, Changpu Yu, Heather Van Epps, Lori Nerbonne, Dennis R. Benjamin	2015	4
6	Abstract 2541: Preclinical results of SGN-CD19A in combination with R-ICE or R-CHOP in non-Hodgkin lymphoma models Cancer Research ·Heather A. Van Epps, Kerry Klussman, Martha E. Anderson, Weiping Zeng, LU Yun-hui, Maureen C. Ryan, Tina Albertson, Che‐Leung Law	2015	3
7	SGN-CD33A: a novel CD33-targeting antibody–drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML Blood ·May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey, Patrick Burke, Changpu Yu, Heather Kostner, Ivan J. Stone, Maureen C. Ryan, Django Sussman, Robert P. Lyon, Weiping Zeng, Kimberly H. Harrington, Kerry Klussman, Lori Westendorf, David W. Meyer, Irwin D. Bernstein, Peter D. Senter, Dennis R. Benjamin, Jonathan G. Drachman, Julie A. McEarchern	2013	291
8	SGN-CD33A: A Novel CD33-Directed Antibody-Drug Conjugate, Utilizing Pyrrolobenzodiazepine Dimers, Demonstrates Preclinical Antitumor Activity Against Multi-Drug Resistant Human AML Blood ·May S.K. Sutherland, Roland B. Walter, Scott C. Jeffrey, Patrick Burke, Changpu Yu, Kimberly H. Harrington, Ivan J. Stone, Maureen C. Ryan, Django Sussman, Weiping Zeng, Dennis R. Benjamin, Irwin D. Bernstein, Peter D. Senter, Jonathan G. Drachman, Julie A. McEarchern	2012	7
9	Targeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody–drug conjugate SGN-75 British Journal of Cancer ·Maureen C. Ryan, Heather Kostner, Karen A. Gordon, Steven Duniho, May Kung Sutherland, Cheng‐Ping Yu, G. E. Stillman, Albina Nesterova, Martha E. Anderson, Julie A. McEarchern, Gaitán Aguilar, Leia M. Smith	2010	68
10	Abstract 4394: Development of parallel conjugation and assay methodologies to screen for antibodies with optimal properties for use as antibody-drug conjugates Cancer Research ·Robert P. Lyon, Maureen C. Ryan, May Kung Sutherland, 罗翔, Changpu Yu, Heather Kostner, Jamie B. Miyamoto, Dennis R. Benjamin	2010	1
11	Targeting of BAFF and APRIL for Autoimmunity and Oncology Advances in experimental medicine and biology ·Maureen C. Ryan, Iqbal S. Grewal	2009	20
12	Preclinical Characterization of SGN-70, a Humanized Antibody Directed against CD70 Clinical Cancer Research ·Julie A. McEarchern, Leia M. Smith, Charlotte F. McDonagh, Kerry Klussman, Kristine A. Gordon, Md Mahbub Ul Karim Khan, Steven Duniho, Maureen C. Ryan, Tamar E. Boursalian, Paul J. Carter, Iqbal S. Grewal, Che‐Leung Law	2008	70
13	CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers British Journal of Cancer ·Leia M. Smith, Albina Nesterova, Maureen C. Ryan, Steven Duniho, Mechthild Jonas, Martha E. Anderson, Roger F. Zabinski, May Kung Sutherland, 양준석, Luidmila Chvyr, Paul A. Moore, Steven M. Ruben, T. Barth	2008	218
14	Abnormal development of glomerular endothelial and mesangial cells in mice with targeted disruption of the lama3 gene Kidney International ·C K Abrass, 王籍, Maureen C. Ryan, Heather Angel Mars-Martins, Kim M. Hansen	2006	31
15	Identification and validation of cell surface antigens for antibody targeting in oncology Endocrine Related Cancer ·Paul Carter, Leia M. Smith, Maureen C. Ryan	2004	90
16	Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion Current Opinion in Cell Biology ·Beth P. Nguyen, Maureen C. Ryan, Susana G. Gil, William G. Carter	2000	216
17	The functions of laminins: Lessons from in vivo studies Matrix Biology ·Maureen C. Ryan, Angela M. Christiano	1996	111
18	Junctional Epidermolysis Bullosis: Defects in Expression of Epiligrin/Nicein/Kalinin and Integrin beta4 That Inhibit Hemidesmosome Formation. Journal of Investigative Dermatology ·Susana G. Gil, Tod A. Brown, Maureen C. Ryan, William G. Carter	1994	17
19	Epiligrin, a new cell adhesion ligand for integrin α3β1 in epithelial basement membranes Cell ·William G. Carter, Maureen C. Ryan, Vandana Arya Hit paper breakdown →	1991	688
20	The human type II procollagen gene: Identification of an additional protein-coding domain and location of potential regulatory sequences in the promoter and first intron Genomics ·Maureen C. Ryan, Isabelle de Melo Xavier Bentinho, Linda J. Sandell	1990	58

About Maureen C. Ryan

Maureen C. Ryan is a scholar working on Immunology and Allergy, Hematology, Oncology, Radiology, Nuclear Medicine and Imaging and Cell Biology, having authored 35 papers that have together received 3.1k indexed citations. Recurring topics across this work include Cell Adhesion Molecules Research (15 papers), HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (10 papers), Multiple Myeloma Research and Treatments (7 papers), Glycosylation and Glycoproteins Research (5 papers), CAR-T cell therapy research (5 papers), Skin and Cellular Biology Research (3 papers) and Acute Myeloid Leukemia Research (3 papers). The work is most often cited by research in Immunology and Allergy (1.3k citations), Cell Biology (906 citations), Oncology (844 citations), Rehabilitation (201 citations) and Hematology (304 citations). Maureen C. Ryan has collaborated with scholars based in United States, South Korea and Germany. Frequent co-authors include William G. Carter, Linda J. Sandell, Susana G. Gil, Yuko Miyashita, Keesook Lee, Leia M. Smith, Richard Tizard, Donald R. VanDevanter, Angela M. Christiano and Beth P. Nguyen. Their work appears in journals such as Cancer Research, Blood, Molecular Cancer Therapeutics, British Journal of Cancer and Journal of Investigative Dermatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact